Brett Cromer

Dr. Brett Cromer

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MSMegan L. Smart
Megan L. Smart
AGAnd Ben J. Gu
And Ben J. Gu
RPRekha Panchal
Rekha Panchal
JWJames Wiley
James Wiley
BCBrett Cromer
Brett Cromer
SPSteven Petrou
Steven Petrou
The importance of the cytosolic C-terminal region of the P2X7 receptor (P2X7R) is unquestioned, yet little is known about the functional domains of this region and how they may contribute to the numerous properties ascribed to this receptor. A structure-function analysis of truncated and single-residue-mutated P2X7 receptors was performed in HEK-293 cells and Xenopus oocytes. Cells expressing receptors truncated at residue 581 (of 595) have negligible ethidium ion uptake, whereas those expressing the P2X7R truncated at position 582 give wild type ethidium ion uptake suggesting that pore formation requires over 95% of the C-terminal tail. Channel function was evident even in receptors that were truncated at position 380 indicating that only a small portion of the cytosolic region is required for channel activity. Surprisingly, truncations in the region between residues 551 and 581 resulted in non-functional receptors with no detectable cell surface expression in HEK-293 cells. A more detailed analysis revealed that mutations of single residues within this region could also abolish receptor function and cell surface expression, suggesting that this region may participate in regulating the surface expression of the pore-forming P2X7R.

1 June 2002 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
BCBrett Cromer
Brett Cromer
CMCraig Morton
Craig Morton
MPMichael Parker
Michael Parker

15 May 2005 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
JMJennifer L. McRae
Jennifer L. McRae
TDThomas G. Duthy
Thomas G. Duthy
KGKim M. Griggs
Kim M. Griggs
RORebecca Ormsby
Rebecca Ormsby
PCPeter J. Cowan
Peter J. Cowan
DGDavid L. Gordon
David L. Gordon
Factor H-related protein 5 (FHR-5) is a recently discovered member of the factor H (fH)-related protein family. FHR proteins are structurally similar to the complement regulator fH, but their biological functions remain poorly defined. FHR-5 is synthesized in the liver and consists of 9 short consensus repeats (SCRs), which display various degrees of homology to those of fH and the other FHR proteins. FHR-5 colocalizes with complement deposits in vivo and binds C3b in vitro, suggesting a role in complement regulation or localization. The current study examined whether rFHR-5 exhibits properties similar to those of fH, including heparin binding, CRP binding, cofactor activity for the factor I-mediated degradation of C3b and decay acceleration of the C3 convertase. rFHR-5 bound heparin-BSA and heparin-agarose and a defined series of truncations expressed in Pichia pastoris localized the heparin-binding region to within SCRs 5–7. rFHR-5 bound CRP, and this binding was also localized to SCRs 5–7. FHR-5 inhibited alternative pathway C3 convertase activity in a fluid phase assay; however, dissociation of the convertase was not observed in a solid phase assay. rFHR-5 displayed factor I-dependent cofactor activity for C3b cleavage, although it was apparently less effective than fH. In addition, we demonstrate association of FHR-5 with high density lipid lipoprotein complexes in human plasma. These results demonstrate that FHR-5 shares properties of heparin and CRP binding and lipoprotein association with one or more of the other FHRs but is unique among this family of proteins in possessing independent complement-regulatory activity.

12 November 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DBDavid N Bowser
David N Bowser
DWDavid A Wagner
David A Wagner
CCCynthia Czajkowski
Cynthia Czajkowski
BCBrett Cromer
Brett Cromer
MPMichael Parker
Michael Parker
SPSteven Petrou
Steven Petrou
The γ-aminobutyric acid type A (GABA A ) receptor mediates fast inhibitory synaptic transmission in the CNS. Dysfunction of the GABA A receptor would be expected to cause neuronal hyperexcitability, a phenomenon linked with epileptogenesis. We have investigated the functional consequences of an arginine-to-glutamine mutation at position 43 within the GABA A γ 2 -subunit found in a family with childhood absence epilepsy and febrile seizures. Rapid-application experiments performed on receptors expressed in HEK-293 cells demonstrated that the mutation slows GABA A receptor deactivation and increases the rate of desensitization, resulting in an accumulation of desensitized receptors during repeated, short applications. In Xenopus laevis oocytes, two-electrode voltage-clamp analysis of steady-state currents obtained from α 1 β 2 γ 2 or α 1 β 2 γ 2 (R43Q) receptors did not reveal any differences in GABA sensitivity. However, differences in the benzodiazepine pharmacology of mutant receptors were apparent. Mutant receptors expressed in oocytes displayed reduced sensitivity to diazepam and flunitrazepam but not the imidazopyridine zolpidem. These results provide evidence of impaired GABA A receptor function that could decrease the efficacy of transmission at inhibitory synapses, possibly generating a hyperexcitable neuronal state in thalamocortical networks of epileptic patients possessing the mutant subunit.

9 May 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BLBogdan Lev
Bogdan Lev
SMSamuel Murail
Samuel Murail
FPFrédéric Poitevin
Frédéric Poitevin
BCBrett Cromer
Brett Cromer
Marc BaadenMarc Baaden
Marc Baaden
TAToby W. Allen
Toby W. Allen
Significance: High-resolution structures of pentameric ligand-gated ion channels have created an opportunity to discover the mechanisms of rapid synaptic transduction in the brain. This study describes the mechanisms of allosteric channel gating using string method simulations, applied to a complete atomistic ion channel, combined with a transition analysis approach to extract free-energy surfaces from swarms of trajectories. We reproduce pH-modulated activity of the channel, identify the molecular interactions associated with interdomain communication, and quantify the energetics of the gating process. These results provide general mechanistic understanding of the function of pentameric ligand-gated channels, with potential applications in the design of improved anesthetics, neuromodulatory drugs, antiparasitics, and pesticides.

1 September 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BBBrett Bennetts
Brett Bennetts
GRGrigori Rychkov
Grigori Rychkov
HNHooi-Ling Ng
Hooi-Ling Ng
CMCraig Morton
Craig Morton
DSDavid Stapleton
David Stapleton
BCBrett Cromer
Brett Cromer
ClC proteins are a family of chloride channels and transporters that are found in a wide variety of prokaryotic and eukaryotic cell types. The mammalian voltage-gated chloride channel ClC-1 is important for controlling the electrical excitability of skeletal muscle. Reduced excitability of muscle cells during metabolic stress can protect cells from metabolic exhaustion and is thought to be a major factor in fatigue. Here we identify a novel mechanism linking excitability to metabolic state by showing that ClC-1 channels are modulated by ATP. The high concentration of ATP in resting muscle effectively inhibits ClC-1 activity by shifting the voltage gating to more positive potentials. ADP and AMP had similar effects to ATP, but IMP had no effect, indicating that the inhibition of ClC-1 would only be relieved under anaerobic conditions such as intense muscle activity or ischemia, when depleted ATP accumulates as IMP. The resulting increase in ClC-1 activity under these conditions would reduce muscle excitability, thus contributing to fatigue. We show further that the modulation by ATP is mediated by cystathionine β-synthase-related domains in the cytoplasmic C terminus of ClC-1. This defines a function for these domains as gating-modulatory domains sensitive to intracellular ligands, such as nucleotides, a function that is likely to be conserved in other ClC proteins.